Epidemiology - The REACT Programme
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-273
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Prof. Paul ElliottResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The REACT programme, the largest of its kind, is a series of studies that are monitoring how the COVID-19 virus is spreading across England. Commissioned by the Department of Health and Social Care, the REACT series of studies are being carried out in partnership with Imperial College Healthcare NHS Trust and Ipsos MORI. The research is offering insight into infection rates broken down by geography, age, sex, ethnicity, key worker status and symptoms. REACT is the largest study of its kind and offers a comprehensive approach to antigen and antibody testing including a large sample (5000+) of keyworkers. REACT 1 and REACT 2 participants are to be followed up via NHS records. Patients who tested positive for COVID-19 (either antigen or antibody) will be followed up for neurological diseases via NHS records.